TIDMSBS

RNS Number : 8317J

Source BioScience PLC

14 September 2016

14 September 2016

Source BioScience plc

(or "the Company")

PDMR dealings

This announcement is made in accordance with Article 19.3 of MAR and Rule 8 of the City Code on Takeovers and Mergers following the exercise of share options granted under the Company's Share Option Schemes on behalf of PDMRs.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 
 1    Details of the person discharging managerial responsibilities / person closely associated 
---  ------------------------------------------------------------------------------------------------------------- 
 a)   Name                                                          Mr Laurie Turnbull 
---  ------------------------------------------------------------  ----------------------------------------------- 
 b)   Position/status                                               PDMR, Chairman 
---  ------------------------------------------------------------  ----------------------------------------------- 
 c)   Initial notification /Amendment                               Initial Notification 
---  ------------------------------------------------------------  ----------------------------------------------- 
 2    Details of the issuer, emission allowance market participant, auction platform, auctioneer 
       or auction monitor 
---  ------------------------------------------------------------------------------------------------------------- 
 a)   Name                                                          Source BioScience plc 
---  ------------------------------------------------------------  ----------------------------------------------- 
 3    Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; and (iv) each place where transactions have been 
       conducted 
---  ------------------------------------------------------------------------------------------------------------- 
 a)   Description of the financial instrument, type of instrument   Ordinary shares of 2p each ("Ordinary Shares") 
       Identification code 
 
                                                                     ISIN Code: GB0009739649 
---  ------------------------------------------------------------  ----------------------------------------------- 
 b)   Nature of the transaction                                     Exercise of share options 
---  ------------------------------------------------------------  ----------------------------------------------- 
 c)   Price(s) and volume(s)                                        Price: Nil 
                                                                     Volume: 298,667 
---  ------------------------------------------------------------  ----------------------------------------------- 
 d)   Aggregated information                                        N/A 
       - Aggregated volume 
       - Price 
---  ------------------------------------------------------------  ----------------------------------------------- 
 e)   Date of the transaction                                       13 September 2016 
---  ------------------------------------------------------------  ----------------------------------------------- 
 f)   Place of the transaction                                      Outside a trading venue 
---  ------------------------------------------------------------  ----------------------------------------------- 
 4    Resultant holding in Ordinary Shares                          3,048,667 (0.8%) 
---  ------------------------------------------------------------  ----------------------------------------------- 
 
 
 1    Details of the person discharging managerial responsibilities / person closely associated 
---  ------------------------------------------------------------------------------------------------------------- 
 a)   Name                                                          Dr Nick Ash 
---  ------------------------------------------------------------  ----------------------------------------------- 
 b)   Position/status                                               PDMR, CEO 
---  ------------------------------------------------------------  ----------------------------------------------- 
 c)   Initial notification /Amendment                               Initial Notification 
---  ------------------------------------------------------------  ----------------------------------------------- 
 2    Details of the issuer, emission allowance market participant, auction platform, auctioneer 
       or auction monitor 
---  ------------------------------------------------------------------------------------------------------------- 
 a)   Name                                                          Source BioScience plc 
---  ------------------------------------------------------------  ----------------------------------------------- 
 3    Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; and (iv) each place where transactions have been 
       conducted 
---  ------------------------------------------------------------------------------------------------------------- 
 a)   Description of the financial instrument, type of instrument   Ordinary shares of 2p each ("Ordinary Shares") 
       Identification code 
 
                                                                     ISIN Code: GB0009739649 
---  ------------------------------------------------------------  ----------------------------------------------- 
 b)   Nature of the transaction                                     Exercise of share options 
---  ------------------------------------------------------------  ----------------------------------------------- 
 c)   Price(s) and volume(s)                                        Price: Nil 
                                                                     Volume: 3,474,965 
---  ------------------------------------------------------------  ----------------------------------------------- 
 d)   Aggregated information                                        N/A 
       - Aggregated volume 
       - Price 
---  ------------------------------------------------------------  ----------------------------------------------- 
 e)   Date of the transaction                                       13 September 2016 
---  ------------------------------------------------------------  ----------------------------------------------- 
 f)   Place of the transaction                                      Outside a trading venue 
---  ------------------------------------------------------------  ----------------------------------------------- 
 4    Resultant holding in Ordinary Shares                          3,974,965 (1.1%) 
---  ------------------------------------------------------------  ----------------------------------------------- 
 
 
 1    Details of the person discharging managerial responsibilities / person closely associated 
---  ------------------------------------------------------------------------------------------------------------- 
 a)   Name                                                          Dr Nick Leaves 
---  ------------------------------------------------------------  ----------------------------------------------- 
 b)   Position/status                                               PDMR, Chief Operating Officer 
---  ------------------------------------------------------------  ----------------------------------------------- 
 c)   Initial notification /Amendment                               Initial Notification 
---  ------------------------------------------------------------  ----------------------------------------------- 
 2    Details of the issuer, emission allowance market participant, auction platform, auctioneer 
       or auction monitor 
---  ------------------------------------------------------------------------------------------------------------- 
 a)   Name                                                          Source BioScience plc 
---  ------------------------------------------------------------  ----------------------------------------------- 
 3    Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; and (iv) each place where transactions have been 
       conducted 
---  ------------------------------------------------------------------------------------------------------------- 
 a)   Description of the financial instrument, type of instrument   Ordinary shares of 2p each ("Ordinary Shares") 
       Identification code 
 
                                                                     ISIN Code: GB0009739649 
---  ------------------------------------------------------------  ----------------------------------------------- 
 b)   Nature of the transaction                                     Exercise of share options 
---  ------------------------------------------------------------  ----------------------------------------------- 
 c)   Price(s) and volume(s)                                        Price: Nil 
                                                                     Volume: 2,867,456 
---  ------------------------------------------------------------  ----------------------------------------------- 
 d)   Aggregated information                                        N/A 
       - Aggregated volume 
       - Price 
---  ------------------------------------------------------------  ----------------------------------------------- 
 e)   Date of the transaction                                       13 September 2016 
---  ------------------------------------------------------------  ----------------------------------------------- 
 f)   Place of the transaction                                      Outside a trading venue 
---  ------------------------------------------------------------  ----------------------------------------------- 
 4    Resultant holding in Ordinary Shares                          3,896,013 (1.1%) 
---  ------------------------------------------------------------  ----------------------------------------------- 
 
 
 1    Details of the person discharging managerial responsibilities / person closely associated 
---  ------------------------------------------------------------------------------------------------------------- 
 a)   Name                                                          Mr Tim Metcalfe 
---  ------------------------------------------------------------  ----------------------------------------------- 
 b)   Position/status                                               PDMR, Group Finance Director 
---  ------------------------------------------------------------  ----------------------------------------------- 
 c)   Initial notification /Amendment                               Initial Notification 
---  ------------------------------------------------------------  ----------------------------------------------- 
 2    Details of the issuer, emission allowance market participant, auction platform, auctioneer 
       or auction monitor 
---  ------------------------------------------------------------------------------------------------------------- 
 a)   Name                                                          Source BioScience plc 
---  ------------------------------------------------------------  ----------------------------------------------- 
 3    Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; and (iv) each place where transactions have been 
       conducted 
---  ------------------------------------------------------------------------------------------------------------- 
 a)   Description of the financial instrument, type of instrument   Ordinary shares of 2p each ("Ordinary Shares") 
       Identification code 
 
                                                                     ISIN Code: GB0009739649 
---  ------------------------------------------------------------  ----------------------------------------------- 
 b)   Nature of the transaction                                     Exercise of share options 
---  ------------------------------------------------------------  ----------------------------------------------- 
 c)   Price(s) and volume(s)                                        Price: Nil 
                                                                     Volume: 1,606,154 
---  ------------------------------------------------------------  ----------------------------------------------- 
 d)   Aggregated information                                        N/A 
       - Aggregated volume 
       - Price 
---  ------------------------------------------------------------  ----------------------------------------------- 
 e)   Date of the transaction                                       13 September 2016 
---  ------------------------------------------------------------  ----------------------------------------------- 
 f)   Place of the transaction                                      Outside a trading venue 
---  ------------------------------------------------------------  ----------------------------------------------- 
 4    Resultant holding in Ordinary Shares                          1,606,154 (0.4%) 
---  ------------------------------------------------------------  ----------------------------------------------- 
 

Enquiries

Source BioScience plc

Dr Nick Ash, Company Secretary

Tel: +44 (0) 115 973 9010

Email: enquiries@sourcebioscience.com

www.sourcebioscience.com

About Source BioScience:

Source BioScience plc (LSE: SBS) is a trusted provider of state of the art Laboratory Services and Products to the healthcare and clinical, life and applied sciences and biopharma industries. It is an international business operating ten state of the art facilities in five countries and with customers in over 90 countries worldwide. The Group offers a complementary portfolio of Laboratory Services and Products that share common technologies, laboratory processes, infrastructure and expertise. These include Diagnostics, DNA Sequencing and Genomics, Analytical and Regulated Services, Clinical Products, Life Science Research Reagents and Controlled Environment for a comprehensive range of applications. These Laboratory Services and Products are provided to a large and diverse customer base including the top 50 pharmaceutical companies, leading universities and research institutes worldwide, the UK NHS and other healthcare providers. The Group is listed on the Premium Main Market of the London Stock Exchange.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHSFAFSLFMSEEU

(END) Dow Jones Newswires

September 14, 2016 06:29 ET (10:29 GMT)

Source Bioscience (LSE:SBS)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Source Bioscience Charts.
Source Bioscience (LSE:SBS)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Source Bioscience Charts.